MOTS-c: Mitochondrial-Derived Peptide Regulation of AMPK & Glucose Homeostasis

MOTS-c (molecular formula C101H152N28O22S2, monoisotopic molecular weight 2174.65 Da) is a 16-amino acid peptide with the sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (MRWQEMGYIFYPRKLR-OH). It is translated from a short open reading frame (sORF) within the mitochondrial 12S ribosomal RNA gene (positions 1389-1436 of human mtDNA).

Unlike nuclear-encoded mitochondrial proteins that travel inward to the organelle, MOTS-c is synthesized within the mitochondrial matrix and exported into the cytoplasm and systemic circulation, acting as an endocrine 'mitokine'.

The primary sequence is amphipathic, featuring a hydrophobic aromatic core (Tyr8, Phe10, Tyr11) flanked by positively charged basic residues (Arg2, Arg13, Lys14, Arg16). This specific charge distribution permits stable association with cell membrane phospholipid bilayers and facilitates nuclear envelope translocation via importin-dependent pathways upon activation.

Under homeostatic conditions with abundant nutrients, MOTS-c resides primarily in the cytoplasm. However, in response to metabolic stress—such as glucose deprivation, oxidative challenge, or exercise-induced energetic depletion—Kim et al. (Cell Metab 2018) demonstrated that MOTS-c undergoes rapid nuclear translocation.

In the nucleus, MOTS-c binds to nuclear receptors and antioxidant response elements (AREs), directly coordinating the expression of over 100 nuclear genes involved in mitochondrial biogenesis, oxidative phosphorylation, and cellular stress resistance.

This nuclear translocation constitutes a bona fide retrograde communication pathway, allowing mitochondrial functional status to directly guide nuclear gene programming to restore homeostatic energy balance.

Lee et al. (Cell Metab 2015) elucidated the unique metabolic mechanism of MOTS-c: metabolomic profiling revealed that MOTS-c selectively inhibits the de novo folate-methionine cycle, specifically blocking 5-methyltetrahydrofolate (5-methyl-THF) utilization.

This targeted blockade leads to the intracellular accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (ZMP), an endogenous monophosphorylated intermediate identical to the pharmacologically active metabolite of AICAR. Accumulated ZMP acts as a natural allosteric mimetic of AMP, directly binding to the gamma-subunit of AMP-activated protein kinase (AMPK).

This binding induces phosphorylation of the critical alpha-subunit activation loop (Thr172) by upstream kinase LKB1, activating AMPK without depleting cellular ATP or increasing the AMP/ATP ratio. Activated AMPK in turn phosphorylates acetyl-CoA carboxylase (ACC), relieving CPT-1 inhibition and accelerating mitochondrial fatty acid oxidation.

In skeletal muscle myotubes (L6 and C2C12 lines), MOTS-c treatment induces rapid translocation of the glucose transporter type 4 (GLUT4) from intracellular storage vesicles to the sarcolemmal plasma membrane, stimulating glucose uptake independently of insulin signaling.

In animal treadmill running assays, Reynolds et al. (Nat Commun 2021) showed that MOTS-c administration in aged mice (22 months old) dramatically enhanced physical performance, doubling maximum running exhaustion time and grip strength compared to age-matched controls, effectively restoring physical capacity to youthful levels.

Furthermore, MOTS-c prevents and reverses diet-induced insulin resistance and hepatic steatosis in high-fat diet DIO models, increasing systemic metabolic flexibility between carbohydrate and lipid fuel utilization.

Analytical MOTS-c is supplied as a sterile lyophilized white powder (molecular weight 2174.65 Da). Because the sequence contains two methionine residues (Met1, Met6), the reconstituted peptide is sensitive to oxidative degradation if exposed to atmospheric oxygen or transition metal contaminants.

Reconstitution calculation: for a standard 10.0 mg vial, adding 2.0 mL of Bacteriostatic Water USP (0.9% benzyl alcohol) yields a working concentration of 5.0 mg/mL (5,000 mcg/mL). Adding 5.0 mL yields 2.0 mg/mL (2,000 mcg/mL).

Syringe calibration on a standard U-100 syringe (100 units = 1.0 mL; 1 unit = 0.01 mL = 50 mcg MOTS-c at 5 mg/mL): a common research dose of 5.0 mg corresponds to 100 units (1.0 mL). At 2.0 mg/mL, a 2.0 mg research dose corresponds to 100 units (1.0 mL).

Solvation instructions: introduce diluent gently down the inside glass wall. Swirl slowly; do not vortex. Complete dissolution occurs in under 60 seconds, yielding an optically clear, colorless solution with pH between 6.5 and 7.5.

Storage parameters: Lyophilized solid vials remain stable at -20°C for up to 36 months, or 2°C–8°C for 18 months. Reconstituted aqueous solution with 0.9% benzyl alcohol must be stored refrigerated at 2°C–8°C, protected from light, and consumed within 21 to 28 days to avoid methionine sulfoxide oxidation.